← Back to patent-cliff list
咪康唑/甲硝唑/利多卡因
Tier C — Watch / tradeMiconazole/Metronidazole/Lidocaine
Exeltis
Originator
2010
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：CYP51A1、Sodium channels
Brand：Neo-Penotran Forte L
Indications (approved)：滴虫感染、念珠菌病、阴道炎
Regional status
US
-
EU
-
China
终止
2008-06-13
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Miconazole/Metronidazole/Lidocaine?
Approved indications include: 滴虫感染, 念珠菌病, 阴道炎.
When does the Miconazole/Metronidazole/Lidocaine patent expire?
No public expiry year is available for Miconazole/Metronidazole/Lidocaine yet; this page updates once verified.
How do I get a quote for Miconazole/Metronidazole/Lidocaine intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24